Evaluation of a programme of cardiovascular disease prevention in primary care: a cluster randomised controlled trial

niversity Hospitals Birmingham NHS Foundation Trust (UK)0 个研究点目标入组 6,250 人2009年5月28日

概览

注册库

who.int

开始日期

2009年5月28日

结束日期

2010年5月1日

最后更新

7年前

研究类型

Interventional

性别

All

发起方

niversity Hospitals Birmingham NHS Foundation Trust (UK)

•Participating practices are identified by the participating primary care trusts.
•Patients for inclusion in the prevention programme are identifed as follows. They must be registered at a participating practice. They must be aged between 35 and 74 and must not currently have coronary heart disease (CHD), not be on the diabetic register and not be currently receiving antihypertensive or statin treatment. From these patients are identified all those patients in whom a combination of risk factors indicates they are likely to be at greater than 20% ten\-year risk of cardiovascular disease. These patients are considered eligible for inclusion in the cardiovascular prevention programme. These patients will be identified from primary care electronic medical records.
•In summary:
•1\. Patients (both males and females) aged between 35 and 74
•2\. Patients who do not have CHD
•3\. Patients who are not diabetic
•4\. Patients who are not receiving antihypertensives or statins
•5\. Patients who are likely to be at greater than 20% ten\-year CVD risk

•Patients who in the opinion of the practice staff are unable to benefit from cardiovascular risk factor assessment. For example, patients who are terminally ill.
•In practice this means that once a list has been created of individuals who are untreated high risk patients are eligible to be invited for cardiovascular risk factor assessment, practice staff will review the list and identify patients who are known to be terminally ill or otherwise unsuitable for inclusion.